Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Hualan's Inactivated Influenza Vaccine (Split Virion)
NCT01554813Phase 3Completed
- Sponsor
- Hualan Biological Engineering Inc.
- Start
- May 2006
- Primary completion
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated influenza vaccine (split virion) in influenza, sponsored by Hualan Biological Engineering Inc.. Started May 2006; status: completed.
02
Drugs
inactivated influenza vaccine (split virion)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01554813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554813.